About Genostics
Genostics is a company based in Sydney (Australia) founded in 2010 by Joachim Fluhrer. It operates as a B2C. Genostics offers products and services including Personalized Cancer Testing and Cancer Treatment Monitoring. Genostics operates in a competitive market with competitors including Denali Therapeutics, PTC Therapeutics, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others.
- Headquarter Sydney, Australia
- Founders Joachim Fluhrer
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genostics
Genostics offers a comprehensive portfolio of products and services, including Personalized Cancer Testing and Cancer Treatment Monitoring. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors cancer treatment effectiveness and tracks status for personalized health insights.
Provides real-time tracking of cancer status to support ongoing medical care.
Funding Insights of Genostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Genostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genostics Comparisons
Competitors of Genostics
Genostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, PTC Therapeutics, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platforms are provided for cancer treatment identification.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genostics
Frequently Asked Questions about Genostics
When was Genostics founded?
Genostics was founded in 2010.
Where is Genostics located?
Genostics is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Who is the current CEO of Genostics?
Joachim Fluhrer is the current CEO of Genostics. They have also founded this company.
What does Genostics do?
Genostics focuses on personalized cancer testing, using advanced technology to monitor treatment effectiveness and track cancer status in real-time. It enables individuals to keep a close eye on their health through innovative diagnostic services. The company emphasizes accurate, timely insights into cancer progression, supporting better health outcomes without specifying locations or clients.
Who are the top competitors of Genostics?
Genostics's top competitors include Juno Therapeutics, PTC Therapeutics and Personalis.
What products or services does Genostics offer?
Genostics offers Personalized Cancer Testing and Cancer Treatment Monitoring.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.